Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors

Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors A Novel Pyrazolo[1,5-a]pyrimidine Is a Potent Inhibitor of Cyclin-Dependent Protein Kinases 1, 2, and 9, Which Demonstrates Antitumor Effects in Human Tumor Xenografts Following Oral Administration Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors Discovery of novel 5-fluoro-N²,N⁴-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9 Pyrazolo[3,4-c]pyridazines as Novel and Selective Inhibitors of Cyclin-Dependent Kinases Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity